{
  "ticker": "SMM",
  "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02968789",
  "id": "02968789",
  "pages": 9,
  "price_sensitive": false,
  "date": "20250711",
  "time": "1759",
  "pdf_url": "https://announcements.asx.com.au/asxpdf/20250711/pdf/06lqr5bd75jgkb.pdf",
  "summary": "### **Material Information Summary (Appendix 3Y \u2013 Change of Director\u2019s Interest Notices)**  \n\n#### **1. Christopher Hansen (Director)**  \n- **Acquired**:  \n  - **10,000,000 Performance Rights** (expiring 11 July 2030) \u2013 Consideration: **$114,391**  \n  - Indirect: **5,555,556 Ordinary Shares** and **2,777,778 Unlisted Options** (exercisable at $0.024 until 30 Sep 2029) \u2013 Consideration: **$50,000 + Nil**  \n- **Nature of Change**: Participation in **Director Placement and Performance Rights**, approved at AGM (12 June 2025).  \n\n#### **2. Michael Edwards (Director)**  \n- **Acquired**:  \n  - **1,111,111 Ordinary Shares** ($10,000)  \n  - **555,556 Unlisted Options** ($0.024, expiring 30 Sep 2029)  \n  - **3,000,000 Performance Rights** (expiring 11 July 2030, $34,317 consideration)  \n- **Nature of Change**: Participation in **Director Placement and Performance Rights**, approved at AGM (12 June 2025).  \n\n#### **3. Melanie Ross (Director)**  \n- **Acquired**: **2,000,000 Performance Rights** (expiring 11 July 2030) \u2013 Consideration: **$22,878**.  \n- **Nature of Change**: Issued under **shareholder-approved Performance Rights** (AGM 12 June 2025).  \n\n### **Key Takeaways**:  \n- **No trades during closed periods**.  \n- **Shareholder approval** underpins all issuances.  \n- **No material disposals**; changes reflect grants/exercises.  \n\n*Format: Strictly factual, omitting legal/boilerplate text.*",
  "usage": {
    "prompt_tokens": 3355,
    "completion_tokens": 395,
    "total_tokens": 3750,
    "prompt_tokens_details": null
  },
  "model": "deepseek/deepseek-chat-v3-0324:free",
  "processed_at": "2025-07-11T08:58:34.167310"
}